लोड हो रहा है...
Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple Sclerosis
OBJECTIVE: To assess safety outcomes for the induction therapies alemtuzumab and autologous hematopoietic stem cell transplantation (AHSCT) compared to noninduction disease-modifying therapies. METHODS: We performed a population-based cohort study linking the Swedish Multiple Sclerosis Register to n...
में बचाया:
| में प्रकाशित: | Neurology |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Lippincott Williams & Wilkins
2021
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8032381/ https://ncbi.nlm.nih.gov/pubmed/33514645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000011545 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|